<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: In the USA, detection of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> is a requirement for enrollment in surveillance programmes for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the UK, it is believed that failure to detect <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> at index endoscopy does not imply its absence within the columnarized segment or that the tissue is not at risk of <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate the factors predicting the probability of detection of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> in the columnarized segment </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: Demonstration of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> was analysed in 3568 biopsies of non-dysplastic <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> from 1751 patients from 7 centres in the UK </plain></SENT>
<SENT sid="4" pm="."><plain>Development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was analysed in 322 patients without <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> and compared with that in 612 patients with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:mpath ids='MPATH_167'>Intestinal metaplasia</z:mpath> was more commonly detected in males than in females (odds ratio 1.244), longer segment length (10.3% increase per centimetre) and increasing number of biopsies taken (24% increase per unit increase) </plain></SENT>
<SENT sid="6" pm="."><plain>After 5 years of follow-up, 54.8% of patients without <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> at index endoscopy demonstrated <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, and 90.8% after 10 years </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant difference in the rate of development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> between patients with or without <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> detection at index endoscopy </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Detection of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> is subject to significant sampling error </plain></SENT>
<SENT sid="9" pm="."><plain>It increases with segment length and number of biopsies taken </plain></SENT>
<SENT sid="10" pm="."><plain>In the majority of patients, if sufficient biopsies are taken over time, <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> will be demonstrated </plain></SENT>
<SENT sid="11" pm="."><plain>The decision to offer surveillance should not be based upon the presence or absence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> at index endoscopy as the risk of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is similar in both groups </plain></SENT>
</text></document>